Staging Procedures to Diagnose Malignant Pleural Mesothelioma

Terminated

• Conditions: Solitary Fibrous Tumor of the Pleura; Mesothelioma

• Registration Number: NCT02648763
• Lead Sponsor: Mayo Clinic

Brief Summary

The purpose of this study is to evaluate the accuracy of participants imaging versus staging procedures. The investigators will consent subjects that are scheduled to undergo staging procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy, endobronchial ultrasound and laparoscopy) as part of their standard of care.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2015-11-20
• Study First Submitted QC: 2016-01-06
• Study First Posted: 2016-01-07
• Study Start: 2016-01-15
• Primary Completion: 2023-04-22
• Study Completion: 2023-04-22
• Status Verified: 2025-01
• Last Update Submitted: 2025-01-10
• Last Update Posted: 2025-01-13

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

• Subject provides informed consent
• Subject is >18 years of age
• Subject is deemed competent for making medical decisions
• Subject is scheduled to undergo a staging pleuroscopy
• Subject is a surgical candidate
• A negative pregnancy test is required in women of child-bearing potential, as standard of care.

Exclusion Criteria

• Subject is <18 years old.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Accuracy of surgical staging versus imaging procedures based on surgical findings.	2 years	The staging imaging will be compared with the actual surgical staging procedure to evaluate the accuracy of the imaging.

Trial Locations

Locations (1)

Mayo Clinic in Rochester; 🇺🇸 Rochester, Minnesota, United States